The discovery that achondroplasia (a well-known skeletal dysplasia in which serum phosphate is unaffected) is caused by activating mutations of an FGF23 receptor (FGFR3), indicated that FGF23-related pathways may affect skeletal development in phosphate-independent manners [101]. Here, FGFR3 is linked to achondroplasia.